Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 7.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:35
Change comment: There is no comment for this version
To version 5.7
edited by Sarantis Dimitriadis
on 2022/06/02 10:56
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,8 +7,6 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 -:
11 -
12 12  * (((
13 13  (% lang="en-US" %)**Non-professional end users:**
14 14  
... ... @@ -17,8 +17,6 @@
17 17  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
18 18  )))
19 19  
20 -:
21 -
22 22  * (((
23 23  (% lang="en-US" %)**Professional end users**
24 24  
... ... @@ -29,13 +29,9 @@
29 29  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
30 30  )))
31 31  
32 -:
33 -
34 34  (% class="western" lang="en-GB" %)
35 35  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
36 36  
37 -:
38 -
39 39  * (((
40 40  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
41 41  
... ... @@ -50,8 +50,6 @@
50 50  * (% lang="en-US" %)Pharmaceutical companies
51 51  )))
52 52  
53 -:
54 -
55 55  * (((
56 56  (% lang="en-GB" %)
57 57  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -67,8 +67,6 @@
67 67  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
68 68  )))
69 69  
70 -:
71 -
72 72  * (((
73 73  (% lang="en-GB" %)
74 74  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -82,8 +82,6 @@
82 82  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
83 83  )))
84 84  
85 -:
86 -
87 87  * (((
88 88  (% lang="en-GB" %)
89 89  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -91,8 +91,6 @@
91 91  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
92 92  )))
93 93  
94 -:
95 -
96 96  * (((
97 97  (% lang="en-GB" %)
98 98  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -100,89 +100,241 @@
100 100  * (% lang="en-US" %)Company cluster organizations and company networks
101 101  * (% lang="en-US" %)International, national, regional and local networks
102 102  )))
87 +
103 103  
104 -:
105 -
106 106  (% class="western" lang="en-GB" %)
107 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
90 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
108 108  
109 -(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %)
110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
92 +(% cellspacing="0" style="border-collapse:collapse; margin-left:auto; margin-right:auto" %)
93 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
94 +(% class="western" lang="en-GB" style="text-align:center" %)
95 +(% lang="en-US" %)**Age or age group**
96 +)))
97 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
98 +(% class="western" lang="en-GB" %)
112 112  (% lang="en-US" %)Specific age range
113 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
100 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
101 +(% class="western" %)
114 114  
115 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
103 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
116 116  (% class="western" %)
117 117  
118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
106 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
119 119  (% class="western" %)
120 120  
121 121  )))
122 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
110 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
111 +(% class="western" lang="en-GB" %)
112 +(% lang="en-US" %)Elderly
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
114 +(% class="western" lang="en-GB" %)
115 +(% lang="en-US" %)Adults
116 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
117 +(% class="western" lang="en-GB" %)
118 +(% lang="en-US" %)Youth
119 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
120 +(% class="western" lang="en-GB" %)
121 +(% lang="en-US" %)Children
122 +)))
123 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
124 124  (% class="western" %)
125 125  
126 126  )))
127 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
128 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
127 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
128 +(% class="western" lang="en-GB" style="text-align:center" %)
129 +(% lang="en-US" %)**Health status**
130 +)))
131 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
129 129  (% class="western" lang="en-GB" %)
130 130  (% lang="en-US" %)Healthy
131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
132 132  (% class="western" lang="en-GB" %)
133 -
134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
136 +(% lang="en-US" %)Patient
137 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
135 135  (% class="western" lang="en-GB" %)
136 -
137 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
139 +(% lang="en-US" %)Rehabilitant
140 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
138 138  (% class="western" lang="en-GB" %)
139 -
142 +(% lang="en-US" %)Recovered/Survivor
140 140  )))
141 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
144 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
142 142  (% class="western" %)
143 143  
144 144  )))
145 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease
147 -|(% style="height:30px; width:153px" %)Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability
148 -|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)
149 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
148 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
149 +(% class="western" lang="en-GB" style="text-align:center" %)
150 +(% lang="en-US" %)**A specific disease, disorder or disability**
151 +)))
152 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
153 +(% class="western" lang="en-GB" %)
154 +(% lang="en-US" %)ADHD
155 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
156 +(% class="western" lang="en-GB" %)
157 +(% lang="en-US" %)Dementia
158 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
159 +(% class="western" lang="en-GB" %)
160 +(% lang="en-US" %)Parkinsons’ disease
161 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
162 +(% class="western" lang="en-GB" %)
163 +(% lang="en-US" %)Loneliness and Social Isolation
164 +)))
165 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
166 +(% class="western" lang="en-GB" %)
167 +(% lang="en-US" %)Autism
168 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
169 +(% class="western" lang="en-GB" %)
170 +(% lang="en-US" %)Down syndrome
171 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
172 +(% class="western" lang="en-GB" %)
173 +(% lang="en-US" %)Physical disability
174 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
175 +(% class="western" lang="en-GB" %)
176 +(% lang="en-US" %)Mental health
177 +)))
178 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
179 +(% class="western" lang="en-GB" %)
180 +(% lang="en-US" %)Cardiovascular disease
181 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
182 +(% class="western" lang="en-GB" %)
183 +(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
184 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
185 +(% class="western" lang="en-GB" %)
186 +(% lang="en-US" %)Sleep apnea/apnea
187 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
188 +(% class="western" lang="en-GB" %)
189 +(% lang="en-US" %)Mild cognitive impairment
190 +)))
191 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
192 +(% class="western" lang="en-GB" %)
193 +(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
194 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
195 +(% class="western" lang="en-GB" %)
196 +(% lang="en-US" %)Language disability
197 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
198 +(% class="western" lang="en-GB" %)
199 +(% lang="en-US" %)Substance abuse (drugs, alcohol)
200 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
201 +(% class="western" lang="en-GB" %)
202 +(% lang="en-US" %)Multiple sclerosis
203 +)))
204 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
205 +(% class="western" lang="en-GB" %)
206 +(% lang="en-US" %)Cognitive disorder (mild, major)
207 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
208 +(% class="western" lang="en-GB" %)
209 +(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
210 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
211 +(% class="western" lang="en-GB" %)
212 +(% lang="en-US" %)Trauma patient
213 +
214 +(% class="western" lang="en-GB" %)
215 +(% lang="en-US" %)(e.g., a spinal cord injury)
216 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
217 +(% class="western" lang="en-GB" %)
218 +(% lang="en-US" %)Neurodegenerative diseases
219 +)))
220 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
150 150  (% class="western" %)
151 151  
152 152  )))
153 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
154 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
224 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
225 +(% class="western" lang="en-GB" style="text-align:center" %)
226 +(% lang="en-US" %)**Clients of a specific service**
227 +)))
228 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
229 +(% class="western" lang="en-GB" %)
230 +(% lang="en-US" %)Child welfare
231 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
232 +(% class="western" lang="en-GB" %)
233 +(% lang="en-US" %)Nursing home
234 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
235 +(% class="western" lang="en-GB" %)
236 +(% lang="en-US" %)Employment service
237 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
155 155  (% class="western" %)
156 156  
157 157  )))
158 -|(% style="height:30px; width:153px" %)Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
241 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
159 159  (% class="western" lang="en-GB" %)
160 -
161 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
243 +(% lang="en-US" %)Early childhood education
244 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
162 162  (% class="western" lang="en-GB" %)
246 +(% lang="en-US" %)Home care
247 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
248 +(% class="western" lang="en-GB" %)
163 163  
164 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
250 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
165 165  (% class="western" lang="en-GB" %)
166 166  
167 167  )))
168 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
254 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
169 169  (% class="western" %)
170 170  
171 171  )))
172 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
173 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
258 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
259 +(% class="western" lang="en-GB" style="text-align:center" %)
260 +(% lang="en-US" %)**Vulnerable groups**
261 +)))
262 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
174 174  (% class="western" lang="en-GB" %)
175 -Down Syndrome
264 +(% lang="en-US" %)Minors/Children
265 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
266 +(% class="western" lang="en-GB" %)
267 +(% lang="en-US" %)Single parents with minor children
268 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
269 +(% class="western" lang="en-GB" %)
270 +(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
271 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
272 +(% class="western" lang="en-GB" %)
273 +(% lang="en-US" %)Substance users
274 +
275 +(% class="western" lang="en-GB" %)
276 +(% lang="en-US" %)(drugs, alcohol)
176 176  )))
177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
278 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
178 178  (% class="western" lang="en-GB" %)
280 +(% lang="en-US" %)Disabled people
281 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
282 +(% class="western" lang="en-GB" %)
283 +(% lang="en-US" %)Victims of trafficking in human beings
284 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
285 +(% class="western" lang="en-GB" %)
286 +(% lang="en-US" %)Ethnic minorities and immigrants
287 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
288 +(% class="western" lang="en-GB" %)
289 +(% lang="en-US" %)Isolated people
290 +)))
291 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
292 +(% class="western" lang="en-GB" %)
293 +(% lang="en-US" %)Elderly people
294 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
295 +(% class="western" lang="en-GB" %)
296 +(% lang="en-US" %)Persons with serious illnesses
297 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
298 +(% class="western" lang="en-GB" %)
299 +(% lang="en-US" %)Homeless people
300 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
301 +(% class="western" lang="en-GB" %)
302 +(% lang="en-US" %)Ex-prisoners and people with criminal background
303 +)))
304 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
305 +(% class="western" lang="en-GB" %)
306 +(% lang="en-US" %)Pregnant women
307 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
308 +(% class="western" lang="en-GB" %)
309 +(% lang="en-US" %)Persons with mental disorders
310 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
311 +(% class="western" lang="en-GB" %)
179 179  
313 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
314 +(% class="western" lang="en-GB" %)
315 +
180 180  )))
317 +\\
181 181  
182 -:
183 183  
184 184  (% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
321 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
186 186  
187 187  |**Researcher expertise**|**Brief use case description**
188 188  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project